ARTL Artelo Biosciences, Inc.

Fundamentals / CIK 0001621221 / USD

Artelo Biosciences, Inc. reported $6.67M in total assets and a net loss of $11.32M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ARTL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2017 to 2025), reported in USD.

$0$0$0-$12.04MFY 2017 Net Income: -$235K2017FY 2018 Net Income: -$2.34M2018FY 2019 Net Income: -$2.17M2019FY 2020 Net Income: -$4.66M2020FY 2021 Net Income: -$7.44M2021FY 2021 Net Income: -$9.41M2021FY 2022 Net Income: -$10.08M2022FY 2023 Net Income: -$9.29M2023FY 2024 Net Income: -$9.83M2024FY 2025 Net Income: -$12.88M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Research & Development $5.42M $5.99M $5.70M $4.32M $3.78M $2.84M $1.92M $1.09M $1.25M --
Total Operating Expenses $11.40M $10.11M $9.93M $10.29M $9.42M $7.44M $4.69M $3.21M $2.34M $233K
Operating Income -$11.40M -$10.11M -$9.93M -$10.29M -$9.42M -$7.44M -$4.69M -$3.21M -$2.34M -$233K
EBITDA -- -- -- -- -- -- -$4.69M -$3.21M -$2.34M --
Interest Expense $194K $0 $0 $5.0K -- $0 -- -- -- $2.1K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$12.88M -$9.83M -$9.29M -$10.08M -$9.41M -$7.44M -$4.66M -$2.17M -$2.34M -$235K
Basic EPS -- -- -- -- -- -$75,687.84 -$238,416.71 -$189,219.61 -$348,164.08 -$5,676.59
Diluted EPS -$395,154.12 -$577,581.51 -$594,149.57 -- -- -$75,687.84 -$238,416.71 -$276,260.63 -$348,164.08 -$5,676.59
Basic Shares Outstanding -- -- -- -- -- 98.7K 19.6K 11 7 46
Diluted Shares Outstanding 33 17 16 -- -- 98.7K 19.6K 11 7 10

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $803K $876K $773K $893K $1.27M $1.87M $1.38M $2.48M
Total Operating Expenses $1.79M $2.50M $2.69M $2.79M $3.09M $3.15M $2.38M $3.81M
Operating Income -$1.79M -$2.50M -$2.69M -$2.79M -$3.09M -$3.15M -$2.38M -$3.81M
Interest Income $24K $42K $1.0K -- $5.0K $1.0K $7.0K --
Interest Expense $0 $6.0K $100K $11K $111K $72K $0 --
Income Tax Expense -- $0 -- $0 $0 $0 $0 $0
Net Income -$1.77M -$2.43M -$2.96M -$4.17M -$3.12M -$3.22M -$2.37M -$3.78M
Diluted EPS -$3.19 -$539.33 -$7,271.85 -- -$88.80 -$10,216.94 -$22,815.42 --
Diluted Shares Outstanding 554.2K 4.5K 406 -- 35.1K 315 104 --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Cash & Cash Equivalents $600K -- -- $6.89M $12.16M $6.63M $2.14M $4.42M $337K $573K
Short-Term Investments -- $0 $7.61M $9.15M $11.95M $3.44M $0 -- -- --
Cash & Short-Term Investments $600K -- -- $16.04M $24.11M $10.06M $2.14M $4.42M $337K $573K
Total Current Assets $695K $2.56M $10.98M $18.32M $24.61M $10.32M $2.34M $4.44M $396K $574K
Property, Plant & Equipment, Net -- -- -- -- -- -- $246 $721 $563 --
Intangible Assets $2.04M $2.04M $2.04M $2.04M $2.04M $2.04M $2.04M $2.04M -- --
Long-Term Investments -- $0 $7.61M $9.15M $11.95M $3.44M -- -- -- --
Other Non-Current Assets -- -- -- $3.0K $3.0K $189K -- -- -- --
Total Non-Current Assets $2.11M $2.14M $2.06M $2.10M $3.64M $2.32M $2.04M $2.04M $563 $0
Total Assets $2.80M $4.70M $13.04M $20.42M $28.25M $12.63M $4.38M $6.48M $397K $574K
Accounts Payable -- -- -- -- -- -- -- $639K -- --
Total Current Liabilities $4.04M $1.77M $1.29M $998K $1.03M $526K $501K $1.02M $532K $29K
Total Non-Current Liabilities $29K $69K $0 $23K $57K $67K $0 $1.2K $0 $0
Total Liabilities $4.07M $1.84M $1.29M $1.02M $1.08M $593K $501K $1.02M $532K $29K
Total Debt (incl. Leases) $69K $104K -- $23K $57K $67K -- -- -- --
Common Stock $0 $1.0K $3.0K $3.0K $3.0K $2.0K $5.0K $3.4K $1.8K $11K
Retained Earnings -$63.02M -$50.14M -$40.31M -$31.02M -$20.94M -$16.90M -$9.47M -$4.81M -$2.64M -$295K
Accumulated Other Comp. Income -$272K -$202K -$203K -$254K -$18K $18K $64K -$9.8K -$12K $657
Total Stockholders' Equity -$1.27M $2.86M $11.75M $19.40M $27.17M $12.04M $3.88M $5.46M -$135K $545K
Total Equity -$1.27M $2.86M $11.75M $19.40M $27.17M $12.04M $3.88M $5.46M -$135K $545K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $4.2K -- $4.20M $600K -- -- -- --
Short-Term Investments -- -- -- -- $0 $0 $0 $0
Cash & Short-Term Investments $4.2K -- $4.20M $600K -- -- -- --
Total Current Assets $4.60M $4.37M $10.42M $695K $1.83M $2.23M $1.38M $2.56M
Intangible Assets $2.04M $2.04M $2.04M $2.04M $2.04M $2.04M $2.04M $2.04M
Long-Term Investments -- -- -- -- -- -- -- $0
Total Non-Current Assets $2.08M $2.09M $2.10M $2.11M $2.44M $2.12M $2.13M $2.14M
Total Assets $6.67M $6.46M $12.52M $2.80M $4.27M $4.36M $3.52M $4.70M
Total Current Liabilities $439K $1.46M $5.83M $4.04M $4.86M $5.71M $2.80M $1.77M
Total Non-Current Liabilities $0 $7.0K $18K $29K $40K $51K $59K $69K
Total Liabilities $439K $1.46M $5.85M $4.07M $4.90M $5.76M $2.86M $1.84M
Total Debt (incl. Leases) $40K $49K $59K $69K $79K $87K $95K $104K
Common Stock $1.0K $4.0K $1.0K $0 $2.0K $1.0K $3.0K $1.0K
Retained Earnings -$70.17M -$68.40M -$65.97M -$63.02M -$58.85M -$55.73M -$52.51M -$50.14M
Accumulated Other Comp. Income -$242K -$242K -$246K -$272K -$277K -$295K -$227K -$202K
Total Stockholders' Equity $6.24M $5.00M $6.67M -$1.27M -$635K -$1.41M $651K $2.86M
Total Equity $6.24M $5.00M $6.67M -$1.27M -$635K -$1.41M $651K $2.86M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Net Income -$12.88M -$9.83M -$9.29M $10.08M -$9.41M $7.44M -$4.66M -$2.17M -$2.34M -$235K
Depreciation & Amortization -- -- -- -- -- -- $500 $510 $282 --
Stock-Based Compensation $1.14M $818K $1.02M $2.46M -- $1.53M $381K $425K $290K $3.3K
Operating Cash Flow -$8.52M -$8.35M -$8.21M -$8.01M -- -$6.14M -$4.35M -$2.79M -$1.61M -$217K
Purchases of Investments $0 -$481K $0 -$499K -- $0 -- -- -- --
Investing Cash Flow -$62K $7.77M $3.51M $2.96M -- -$3.44M $0 -$1.50M -$845 --
Common Stock Issued $6.15M $112K $567K $0 -- $8.10M $1.98M $8.38M $1.39M $773K
Financing Cash Flow $6.87M $112K $567K $0 -- $14.11M $1.98M $8.38M $1.39M $785K
Net Change in Cash -$1.74M -$477K -$4.07M -$5.27M -- $4.49M -$2.28M $4.09M -$235K $569K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.77M -$2.43M -$2.96M -$4.17M -$3.12M -$3.22M -$2.37M -$15.87M
Stock-Based Compensation -$354K $570K $401K $368K $432K $150K $192K $201K
Operating Cash Flow -$2.62M -$5.03M -$1.19M -$2.91M -$3.50M -$514K -$1.60M -$2.57M
Purchases of Investments -- -- -- $0 $0 $0 $0 $0
Investing Cash Flow -- -- -- $188K -$250K $0 $0 $500K
Common Stock Issued $2.86M $175K $10.03M $1.76M $3.31M $1.08M $0 $57K
Financing Cash Flow $2.86M -$1.06M $10.86M $1.61M $3.44M $1.82M $0 $57K
Net Change in Cash $239K -$6.08M $9.67M -$1.12M -$346K $1.32M -$1.59M -$2.02M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Return on Equity (ROE) -- -344.0% -79.0% -52.0% -34.6% -61.8% -120.1% -39.8% -- -43.1%
Return on Assets (ROA) -459.8% -209.2% -71.2% -49.4% -33.3% -58.9% -106.4% -33.5% -590.3% -40.9%
Current Ratio 0.17x 1.44x 8.51x 18.36x 23.96x 19.61x 4.66x 4.35x 0.75x 19.51x
Quick Ratio 0.15x -- -- 16.07x 23.48x 19.13x 4.28x 4.33x 0.63x 19.46x
Debt to Equity -- 0.04x -- 0.00x 0.00x 0.01x -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -181.5% -253.6% -201.8% -- -- -- -1492.3% -344.0%
Return on Assets (ROA) -169.6% -196.2% -107.6% -459.8% -292.7% -241.1% -276.4% -209.2%
Current Ratio 10.47x 3.00x 1.79x 0.17x 0.38x 0.39x 0.49x 1.44x
Quick Ratio 0.01x -- 0.72x 0.15x -- -- -- --
Debt to Equity 0.01x 0.01x 0.01x -- -- -- 0.15x 0.04x
Source: SEC EDGAR CompanyFacts (CIK 0001621221) · from February 28, 2014 Data through September 30, 2026 · synced Nov 21, 2026, 05:08 UTC · Open in terminal